| Haeoh M Jung, MD | |
|
325 S Belmont St, York, PA 17403-2608 | |
| (717) 843-8623 | |
| Not Available |
| Full Name | Haeoh M Jung |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 325 S Belmont St, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275518573 | NPI | - | NPPES |
| 001625437 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD058147L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Redeemer Hospital And Medical Center | Meadowbrook, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huntingdon Valley Anesthesia Associates | 6406742642 | 29 |
News Archive
Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with schizophrenia.
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Gov. Gavin Newsom has proposed bold steps to ensure more Californians have health coverage, but a new report underscores that his success may depend in part on large-scale investments to expand the state's health care workforce.
› Verified 4 days ago
| Entity Name | Associates In Anesthesia, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942281191 PECOS PAC ID: 9335052034 Enrollment ID: O20031124000710 |
News Archive
Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with schizophrenia.
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Gov. Gavin Newsom has proposed bold steps to ensure more Californians have health coverage, but a new report underscores that his success may depend in part on large-scale investments to expand the state's health care workforce.
› Verified 4 days ago
| Entity Name | Huntingdon Valley Anesthesia Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710933114 PECOS PAC ID: 6406742642 Enrollment ID: O20040225000439 |
News Archive
Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with schizophrenia.
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Gov. Gavin Newsom has proposed bold steps to ensure more Californians have health coverage, but a new report underscores that his success may depend in part on large-scale investments to expand the state's health care workforce.
› Verified 4 days ago
| Entity Name | West Chester Anesthesia Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245252147 PECOS PAC ID: 4880585884 Enrollment ID: O20040322000031 |
News Archive
Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with schizophrenia.
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Gov. Gavin Newsom has proposed bold steps to ensure more Californians have health coverage, but a new report underscores that his success may depend in part on large-scale investments to expand the state's health care workforce.
› Verified 4 days ago
| Entity Name | Northstar Anesthesia Of Pennsylvania Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700218989 PECOS PAC ID: 5092941161 Enrollment ID: O20131119001358 |
News Archive
Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with schizophrenia.
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Gov. Gavin Newsom has proposed bold steps to ensure more Californians have health coverage, but a new report underscores that his success may depend in part on large-scale investments to expand the state's health care workforce.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Haeoh M Jung, MD 930 Hillcrest Dr, Kinzers, PA 17535-9620 Ph: (215) 858-0203 | Haeoh M Jung, MD 325 S Belmont St, York, PA 17403-2608 Ph: (717) 843-8623 |
News Archive
Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of treatment options with their patients living with schizophrenia.
CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate tumors in mice without causing autoimmune problems. Researchers also found evidence that the same mechanism may operate in humans. The study was published today in the advance online edition of Nature.
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB).
Gov. Gavin Newsom has proposed bold steps to ensure more Californians have health coverage, but a new report underscores that his success may depend in part on large-scale investments to expand the state's health care workforce.
› Verified 4 days ago
Van D Adams, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 325 S Belmont St, York, PA 17403 Phone: 717-843-8623 | |
Surendra Davuluri, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2345 | |
Sudhakar Reddy Yennam, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, York, PA 17403 Phone: 717-812-7687 | |
Dr. Michael Allen Klein, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 Fax: 717-741-9539 | |
Barrett E Giffel, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd Ste 270, York, PA 17403 Phone: 717-741-8250 Fax: 717-741-8289 | |
Daniel Derewitz, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2345 | |
Claudia Deitrich, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2345 |